| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $601K | +5.4% |
| R&D Expense | $12.5M | -24.3% |
| SG&A Expense | $6.8M | -1.3% |
| Operating Income | -$18.7M | +18.1% |
| Interest Expense | $2K | +100.0% |
| Pre-tax Income | -$18.6M | +8.0% |
| Income Tax | $0 | — |
| Net Income | -$18.6M | +8.0% |
| EPS (Basic) | -$8.88 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.1M | -27.9% |
| Accounts Receivable | $838K | -12.8% |
| Current Assets | $2.5M | -24.4% |
| Total Assets | $2.6M | -28.5% |
| Current Liabilities | $5.1M | -14.1% |
| Long-term Debt | $0 | -100.0% |
| Total Liabilities | $5.1M | -14.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.2M | +6.1% |
| Capital Expenditures | $22K | -67.2% |
| Investing Cash Flow | -$22K | +67.2% |
| Financing Cash Flow | $15.8M | +26.8% |
| Free Cash Flow | -$16.2M | +6.3% |
| +79.7% |
| EPS (Diluted) | -$8.88 | +79.7% |
| Stockholders' Equity |
| -$2.5M |
| -7.7% |